As part of its five-year strategic plan, Prevent Blindness has promoted five individuals to further the organization’s mission. Prevent Blindness has promoted five leaders to further its efforts and ...

A new study found that an artificial intelligence reading label system improves ophthalmologists' diagnostic accuracy for retinal diseases and could be valuable in future medical education. A new ...

Pykus Therapeutics announced it has completed enrollment in its pilot study, PYK-2101-RD00, evaluating PYK-2101, a focal hydrogel retinal sealant, in patients undergoing surgery for detached retina.

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to severe NPDR without center-involved diabetic macular edema (CI-DME). Vantage ...

Aviceda Therapeutics recently appointed Jeffrey Nau, PhD, MMS, as chief executive officer. Nau comes to Aviceda with more than 20 years of experience leading and expanding biotechnology and ...

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations. Researchers from the ...

The ZAP-X system is described by researchers as a "dedicated, self-contained, and self-shielded surgical robot" designed for performing stereotactic surgery (SRS) on the brain, head, and neck. This ...

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset. Taiwanese investigators found in their cohort ...

Novelty Nobility, a Korean antibody drug discovery company, recently announced it has been selected to join JLABS Korea. 1 JLABS, part of Johnson & Johnson’s global incubator network, supports ...